# BioMarin Pharmaceutical Inc. – aktieanalysens källarkiv

Company page: https://spela.port0.org/company/biomarin-pharmaceutical-inc
Company JSON: https://spela.port0.org/company/biomarin-pharmaceutical-inc/company.json
Documents JSON: https://spela.port0.org/company/biomarin-pharmaceutical-inc/documents.json
Updated: 2026-08-06T07:27:23Z

## Market data
- Nasdaq kurshistorik CSV: https://spela.port0.org/company/biomarin-pharmaceutical-inc/market/history.csv
- Nasdaq kurshistorik JSON: https://spela.port0.org/company/biomarin-pharmaceutical-inc/market/history.json
- Nasdaq manifest JSON: https://spela.port0.org/company/biomarin-pharmaceutical-inc/market/manifest.json
- SEC Company Facts JSON: https://spela.port0.org/company/biomarin-pharmaceutical-inc/market/sec-companyfacts.json
- SEC filing-manifest JSON: https://spela.port0.org/company/biomarin-pharmaceutical-inc/market/sec-manifest.json
- SEC sammanfattning JSON: https://spela.port0.org/company/biomarin-pharmaceutical-inc/market/sec-summary.json

## Full-text source documents
- SEC EDGAR | 8-K – 2026-07-13 – bmrn-20260427.htm: https://spela.port0.org/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2026-07-13-bmrn-20260427-htm/fulltext.txt
- SEC EDGAR | 8-K – 2026-06-04 – bmrn-20260602.htm: https://spela.port0.org/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2026-06-04-bmrn-20260602-htm/fulltext.txt
- SEC EDGAR | 10-Q – 2026-05-05 – bmrn-20260331.htm: https://spela.port0.org/company/biomarin-pharmaceutical-inc/documents/sec-edgar-10-q-2026-05-05-bmrn-20260331-htm/fulltext.txt
  - HTML part 1: https://spela.port0.org/company/biomarin-pharmaceutical-inc/documents/sec-edgar-10-q-2026-05-05-bmrn-20260331-htm/part-001.html
  - HTML part 2: https://spela.port0.org/company/biomarin-pharmaceutical-inc/documents/sec-edgar-10-q-2026-05-05-bmrn-20260331-htm/part-002.html
- SEC EDGAR | 8-K – 2026-05-04 – bmrn-20260504.htm: https://spela.port0.org/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2026-05-04-bmrn-20260504-htm/fulltext.txt
- SEC EDGAR | 8-K – 2026-04-27 – d113922d8k.htm: https://spela.port0.org/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2026-04-27-d113922d8k-htm/fulltext.txt
- SEC EDGAR | 8-K – 2026-04-23 – d139584d8k.htm: https://spela.port0.org/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2026-04-23-d139584d8k-htm/fulltext.txt
- SEC EDGAR | 8-K – 2026-03-16 – d114815d8k.htm: https://spela.port0.org/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2026-03-16-d114815d8k-htm/fulltext.txt
- SEC EDGAR | 10-K – 2026-02-26 – bmrn-20251231.htm: https://spela.port0.org/company/biomarin-pharmaceutical-inc/documents/sec-edgar-10-k-2026-02-26-bmrn-20251231-htm/fulltext.txt
  - HTML part 1: https://spela.port0.org/company/biomarin-pharmaceutical-inc/documents/sec-edgar-10-k-2026-02-26-bmrn-20251231-htm/part-001.html
  - HTML part 2: https://spela.port0.org/company/biomarin-pharmaceutical-inc/documents/sec-edgar-10-k-2026-02-26-bmrn-20251231-htm/part-002.html
  - HTML part 3: https://spela.port0.org/company/biomarin-pharmaceutical-inc/documents/sec-edgar-10-k-2026-02-26-bmrn-20251231-htm/part-003.html
  - HTML part 4: https://spela.port0.org/company/biomarin-pharmaceutical-inc/documents/sec-edgar-10-k-2026-02-26-bmrn-20251231-htm/part-004.html
- SEC EDGAR | 8-K – 2026-02-23 – bmrn-20260223.htm: https://spela.port0.org/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2026-02-23-bmrn-20260223-htm/fulltext.txt
- SEC EDGAR | 8-K – 2026-02-12 – d63881d8k.htm: https://spela.port0.org/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2026-02-12-d63881d8k-htm/fulltext.txt
- SEC EDGAR | 8-K – 2026-01-29 – d170996d8k.htm: https://spela.port0.org/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2026-01-29-d170996d8k-htm/fulltext.txt
- SEC EDGAR | 8-K – 2026-01-26 – d100834d8k.htm: https://spela.port0.org/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2026-01-26-d100834d8k-htm/fulltext.txt
- SEC EDGAR | 8-K – 2026-01-12 – d93149d8k.htm: https://spela.port0.org/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2026-01-12-d93149d8k-htm/fulltext.txt
- SEC EDGAR | 8-K – 2025-12-22 – d45090d8k.htm: https://spela.port0.org/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2025-12-22-d45090d8k-htm/fulltext.txt
- SEC EDGAR | 8-K – 2025-12-19 – d49247d8k.htm: https://spela.port0.org/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2025-12-19-d49247d8k-htm/fulltext.txt
- SEC EDGAR | 8-K – 2025-12-17 – d848371d8k.htm: https://spela.port0.org/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2025-12-17-d848371d8k-htm/fulltext.txt
- SEC EDGAR | 10-Q – 2025-10-28 – bmrn-20250930.htm: https://spela.port0.org/company/biomarin-pharmaceutical-inc/documents/sec-edgar-10-q-2025-10-28-bmrn-20250930-htm/fulltext.txt
  - HTML part 1: https://spela.port0.org/company/biomarin-pharmaceutical-inc/documents/sec-edgar-10-q-2025-10-28-bmrn-20250930-htm/part-001.html
  - HTML part 2: https://spela.port0.org/company/biomarin-pharmaceutical-inc/documents/sec-edgar-10-q-2025-10-28-bmrn-20250930-htm/part-002.html
- SEC EDGAR | 8-K – 2025-10-27 – bmrn-20251027.htm: https://spela.port0.org/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2025-10-27-bmrn-20251027-htm/fulltext.txt
- SEC EDGAR | 8-K – 2025-10-07 – bmrn-20251007.htm: https://spela.port0.org/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2025-10-07-bmrn-20251007-htm/fulltext.txt
- SEC EDGAR | 8-K – 2025-08-11 – bmrn-20250805.htm: https://spela.port0.org/company/biomarin-pharmaceutical-inc/documents/sec-edgar-8-k-2025-08-11-bmrn-20250805-htm/fulltext.txt